Qiagens Upcoming Sample Preparation Instruments Expanding Automated Solutions For Laboratories

The provided source material is insufficient to produce a 2000-word article about QIAGEN free samples. Below is a factual summary based on available data.

QIAGEN, a Netherlands-based holding company and leading global provider of Sample to Insight solutions, is advancing plans to launch three new sample preparation instruments during 2025 and 2026. These instruments are designed to expand QIAGEN's portfolio for automated sample preparation and address different customer segments across laboratories worldwide.

The upcoming instrument launches include:

  1. QIAsymphony Connect: Set to begin a phased launch to selected customers starting in 2025, this system represents the next generation of QIAGEN's flagship QIAsymphony product, which has over 3,300 cumulative placements. The first customer sessions are being held to highlight enhanced capabilities for oncology and genomics workflows.

  2. QIAsprint Connect: On track for launch in 2026, this system marks QIAGEN's entry into automated high-throughput sample processing. It can process up to 192 samples per run with less than 30 minutes of hands-on time, enabling labs to scale up to 600 samples per day. The system supports both pre-programmed and customizable protocols and features consumables designed to reduce plastic waste by up to 50%.

  3. QIAmini: Also planned for a 2026 launch, this instrument expands QIAGEN's automation portfolio into the low-throughput segment. It offers a cost-effective and low-complexity entry into automation, bringing the reliability of QIAGEN trusted kits to smaller labs and batch sizes. The system is ideal for replacing tedious pipetting, delivering the reproducibility of automation with flexibility to scale as needed.

These new systems complement QIAGEN's existing portfolio, including the updated QIAcube Connect and EZ2 Connect systems. Together, they reflect QIAGEN's strategy to provide modular, scalable solutions in sample preparation that match evolving lab needs from small research settings to high-volume testing labs.

The QIAsprint Connect has demonstrated its potential to process a wide range of sample types, including plant, microbial, soil, stool, and human tissues. It is already being used to develop nine different applications, making it suitable for labs working across various areas.

According to QIAGEN, these new instruments underscore the company's commitment to helping labs operate more efficiently, sustainably, and flexibly. The company serves more than 500,000 customers worldwide in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics).

QIAGEN describes itself as providing solutions that cover every step along the journey from samples to insights - including sample technologies, assays, bioinformatics software, and automation solutions that tie these together in seamless workflows.

The source material does not contain information about consumer-facing free samples, promotional offers, no-cost product trials, brand freebies, or mail-in sample programs for categories such as beauty, baby care, pet products, health, food, or household goods.

Sources

  1. QIAGEN Press Release on New Sample Preparation Instruments
  2. QIAGEN Corporate Information
  3. QIAGEN Home Page
  4. QIAGEN US Products Page